GAMP 5 & GxP Computerised Systems Guidance
Computerised System Retirement and Data Migration Under GAMP 5 Understanding System Retirement in the GxP Environment The pharmaceutical industry is under continuous scrutiny to uphold quality and regulatory requirements. As part of good practice (GxP) guidelines, the process of system retirement is a crucial component in ensuring that legacy systems do not compromise quality compliance and data integrity. Regulatory bodies…
Using GAMP 5 to Prioritise Legacy System Remediation and Modernisation Using GAMP 5 to Prioritise Legacy System Remediation and Modernisation Managing legacy systems in pharmaceutical environments is a complex yet critical aspect of maintaining compliance with industry regulations. As technology evolves, companies face the pressing need to modernise these systems while adhering to Good Automated Manufacturing Practice (GAMP 5) guidelines….
GAMP 5 and Agile Software Development: Making Validation Work with Agile GAMP 5 and Agile Software Development: Making Validation Work with Agile Introduction to Pharmaceutical Validation in Agile Development Pharmaceutical validation is a cornerstone of compliance with Good Manufacturing Practices (cGMP) as stipulated by regulatory authorities like the US FDA, EMA, and PIC/S. As software development increasingly adopts agile methodologies,…
Audit and Inspection Readiness for GxP Systems Under GAMP 5 Audit and Inspection Readiness for GxP Systems Under GAMP 5 In the highly regulated pharmaceutical industry, ensuring the integrity and compliance of Good Automated Manufacturing Practice (GxP) systems is paramount. This comprehensive guide details the steps to achieve GAMP 5 audit readiness, equipping organizations with the knowledge to prepare their…
Training and Competency Frameworks for GAMP 5 and CSV Teams Training and Competency Frameworks for GAMP 5 and CSV Teams In the rapidly evolving landscape of pharmaceutical manufacturing and regulatory compliance, implementing effective training frameworks for GAMP 5 and Computerized System Validation (CSV) teams is essential. Organizations must establish these frameworks to ensure that personnel possess the necessary skills and…
GAMP 5 Considerations for MES and Electronic Batch Record Systems In the rapidly evolving landscape of pharmaceutical manufacturing, ensuring compliance with good manufacturing practice (GMP) regulations is critical. Among the essential frameworks guiding the validation of computerized systems is the Good Automated Manufacturing Practice (GAMP) 5, particularly concerning Manufacturing Execution Systems (MES) and electronic batch record (EBR) systems. This comprehensive…
GAMP 5 for Laboratory Systems: LIMS, CDS and Bioanalytical Platforms In the ever-evolving pharmaceutical and biotechnological landscapes, the regulatory expectations for validation of laboratory systems are critical. The use of automated systems such as Laboratory Information Management Systems (LIMS), Chromatography Data Systems (CDS), and bioanalytical platforms are governed by stringent guidelines laid out by international regulatory authorities. Among these, GAMP…
Using GAMP 5 to Strengthen Data Integrity Risk Assessments for GxP Systems Using GAMP 5 to Strengthen Data Integrity Risk Assessments for GxP Systems In today’s regulatory environment, ensuring data integrity in Good Practice (GxP) systems is paramount for pharmaceutical and biotechnology organizations. The challenges associated with GxP data integrity risk assessment can be effectively addressed using the GAMP 5…
End-to-End GxP System Lifecycle: From Concept to Retirement Under GAMP 5 End-to-End GxP System Lifecycle: From Concept to Retirement Under GAMP 5 Introduction to the GAMP 5 Lifecycle The Good Automated Manufacturing Practice (GAMP) 5 guidance provides a structured approach to the lifecycle of computerized systems used in regulated environments, particularly in the fields of pharmaceuticals and biotechnology. The GAMP…